⌘K

Login Start Free

Home/Filings/4/0001102624-13-000289

4//SEC Filing

Farah John M JR 4

Accession 0001102624-13-000289

CIK 0001261734other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 6:08 PM ET

Size

35.3 KB

Accession

0001102624-13-000289

Insider Transaction Report

Form 4

Period: 2011-02-10

AEOLUS PHARMACEUTICALS, INC.AOLS

Farah John M JR

Director

Transactions

Award
Non-qualified Stock Option (right to buy)
2011-02-10+3,750→ 3,750 total
Exercise: $0.80Exp: 2021-02-10→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2011-04-13+11,250→ 11,250 total
Exercise: $0.50Exp: 2021-04-13→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2011-05-16+3,750→ 3,750 total
Exercise: $0.40Exp: 2021-05-16→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2011-06-13+3,750→ 3,750 total
Exercise: $0.54Exp: 2021-06-13→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2011-08-11+3,750→ 3,750 total
Exercise: $0.44Exp: 2021-08-11→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2011-11-07+11,250→ 11,250 total
Exercise: $0.40Exp: 2021-11-07→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2011-12-14+3,750→ 3,750 total
Exercise: $0.40Exp: 2021-12-14→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-02-10+3,750→ 3,750 total
Exercise: $0.35Exp: 2022-02-10→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-03-20+11,250→ 11,250 total
Exercise: $0.31Exp: 2022-03-20→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-05-14+3,750→ 3,750 total
Exercise: $0.30Exp: 2022-05-14→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-07-11+11,250→ 11,250 total
Exercise: $0.23Exp: 2022-07-11→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-08-13+3,750→ 3,750 total
Exercise: $0.30Exp: 2022-08-13→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-10-09+11,250→ 11,250 total
Exercise: $0.35Exp: 2022-10-09→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2013-02-12+3,750→ 3,750 total
Exercise: $0.25Exp: 2023-02-12→ Common Stock (3,750 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-12-27+3,750→ 3,750 total
Exercise: $0.24Exp: 2022-12-27→ Common Stock (3,750 underlying)

Footnotes (1)

[F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeother

Related Parties

1

filerCIK 0001342458

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 6:08 PM ET
Size: 35.3 KB

View on SEC.gov